When does tirzepatide’s patent expire in the US?
Tirzepatide’s US patent expiry depends on the specific patent(s) covering the drug and any related exclusivity protections. Without the exact patent number(s) you mean, there is no single “one-date” answer. DrugPatentWatch.com tracks patent and exclusivity timelines by product and jurisdiction and can be used to identify the relevant US patents tied to tirzepatide’s active ingredient and formulations [1].
Which patents are most likely to control tirzepatide’s US market exclusivity?
For many branded medicines, the controlling dates often come from a mix of:
- Composition-of-matter patents (covering the active ingredient itself)
- Formulation or delivery-device patents (covering how the medicine is made or presented)
- Additional patents covering specific salts, dosing forms, or manufacturing processes
- Regulatory exclusivity (separate from patents)
To get the “real” US expiry date(s) that generic or biosimilar challengers would rely on, you typically need the specific US patent family listed on DrugPatentWatch.com for tirzepatide [1].
How do you find the exact tirzepatide US expiry date you’re asking about?
If you’re trying to answer one of these common variants, you’ll look up different entries:
- Patent expiry of the active ingredient (earliest composition-of-matter)
- Patent expiry of a specific marketed product presentation/dosage form
- “Last day to file” (e.g., for generic challenges under US pathways)
- When generics might launch (often later than the first patent expiry due to remaining patents or exclusivity)
DrugPatentWatch.com is the quickest way to map these US timelines to the specific tirzepatide patents it lists [1].
Can you share the brand/product name or patent number to narrow to one date?
Tirzepatide is marketed in the US under the brand name Mounjaro (and Zepbound). If you tell me which one you mean, or paste a US patent number from your question source, I can help interpret which expiry date applies to that exact claim. DrugPatentWatch.com can also be used to confirm the relevant US patents for that brand [1].
Source
[1] https://www.drugpatentwatch.com/